These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9014759

  • 1. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
    Johnston PG, Geoffrey F, Drake J, Voeller D, Grem JL, Allegra CJ.
    Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
    [Abstract] [Full Text] [Related]

  • 2. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T, Nakano S, Tatsumoto T, Kuroki-Migita M, Mitsugi K, Nakamura M, Niho Y.
    Cancer Res; 1992 Dec 01; 52(23):6501-6. PubMed ID: 1423296
    [Abstract] [Full Text] [Related]

  • 3. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R, Tanabe K, Inoue H, Toge T.
    Int J Oncol; 2002 Mar 01; 20(3):549-55. PubMed ID: 11836567
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Mar 01; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E, Zinn S, Boarman D, Allegra CJ.
    Cancer Res; 1990 Sep 15; 50(18):5834-40. PubMed ID: 1697502
    [Abstract] [Full Text] [Related]

  • 8. Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines.
    Mans DR, Grivicich I, Peters GJ, Schwartsmann G.
    Eur J Cancer; 1999 Dec 15; 35(13):1851-61. PubMed ID: 10674003
    [Abstract] [Full Text] [Related]

  • 9. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL, Erlichman C.
    Cancer Chemother Pharmacol; 1992 Dec 15; 30(5):370-6. PubMed ID: 1380407
    [Abstract] [Full Text] [Related]

  • 10. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
    Perez EA, Hack FM, Webber LM, Chou TC.
    Cancer Chemother Pharmacol; 1993 Dec 15; 33(3):245-50. PubMed ID: 8269606
    [Abstract] [Full Text] [Related]

  • 11. Effect of consecutive lower-dose cisplatin in enhancement of 5-fluorouracil cytotoxicity in experimental tumor cells in vivo.
    Araki H, Fukushima M, Kamiyama Y, Shirasaka T.
    Cancer Lett; 2000 Nov 28; 160(2):185-91. PubMed ID: 11053648
    [Abstract] [Full Text] [Related]

  • 12. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q, Van Groeningen CJ, Hardcastle A, Aherne GW, Geoffroy F, Allegra CJ, Johnston PG, Grem JL.
    Oncol Res; 1997 Nov 28; 9(2):77-88. PubMed ID: 9167189
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil].
    Shirasaka T, Shimamoto Y, Ohshimo H, Kimura A, Fukushima M.
    Gan To Kagaku Ryoho; 1991 Mar 28; 18(3):403-9. PubMed ID: 2003740
    [Abstract] [Full Text] [Related]

  • 14. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M, Liu X.
    Chin Med J (Engl); 1999 Apr 28; 112(4):336-9. PubMed ID: 11593534
    [Abstract] [Full Text] [Related]

  • 15. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
    Kishimoto H, Manno Y, Tanaka H, Moridera K, Urade M.
    Gan To Kagaku Ryoho; 2001 Apr 28; 28(4):505-9. PubMed ID: 11329785
    [Abstract] [Full Text] [Related]

  • 16. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D, Qu J, Qu X, Cao Y, Xu L, Hou K, Feng W, Liu Y.
    Cancer Chemother Pharmacol; 2015 Sep 28; 76(3):575-86. PubMed ID: 26208739
    [Abstract] [Full Text] [Related]

  • 17. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo.
    Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M.
    Cancer Chemother Pharmacol; 1993 Sep 28; 32(3):167-72. PubMed ID: 8500219
    [Abstract] [Full Text] [Related]

  • 18. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
    Chu E, Koeller DM, Johnston PG, Zinn S, Allegra CJ.
    Mol Pharmacol; 1993 Apr 28; 43(4):527-33. PubMed ID: 8474431
    [Abstract] [Full Text] [Related]

  • 19. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway.
    Takizawa K, Kamijo R, Ito D, Hatori M, Sumitani K, Nagumo M.
    Br J Cancer; 1999 Jun 28; 80(7):954-63. PubMed ID: 10362102
    [Abstract] [Full Text] [Related]

  • 20. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A, Aschele C, Mori A, Baldo C, Russo P, Debernardis D, Valenti M, Bruno S, Taverna M, Rosso R.
    Clin Cancer Res; 1995 Nov 28; 1(11):1337-44. PubMed ID: 9815929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.